Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

'Significant potential' for new swine flu strains
pigs
Regular outbreaks of influenza A viruses are seen in humans and pigs - most commonly H1 and H3 subtypes.
Largest ever dataset of antigenic variation created
 
Scientists say there is 'significant potential' for the emergence of new swine flu strains, due to the wide diversity of flu in pigs across multiple continents. These strains present a serious threat to public health, as they are no longer similar enough to current human flu strains for our immune systems to recognise them.

When flu viruses are transmitted from humans to pigs, they continue to evolve their surface proteins (or antigens), explained lead author Nicola Lewis from the University of Cambridge. This results in a large diversity of novel flu viruses, which can then be transmitted to pigs and humans.

Regular outbreaks of influenza A viruses are seen in humans and pigs - most commonly H1 and H3 subtypes. But there is a lack of data on the diversity of their antigens, which shapes their pandemic potential.

Dr Lewis and her team say they have created the largest and most geographically comprehensive dataset of antigenic variation. It encompasses nearly 600 flu viruses from 1930-2013, covering multiple continents including Europe, the US and Asia. Nearly 200 of the viruses had never been studied before.

Findings published in the journal eLife suggest the amount of variation in swine flu viruses is similar to that in H1 and H3 viruses seen in humans for the past 40 years. This has been driven by the frequent transmission of human viruses to pigs.

Dr Lewis commented: "Since most of the current swine flu viruses are the result of human seasonal flu virus introductions into pigs, we anticipate at least some cross-protective immunity in the human population, which could potentially interfere with a re-introduction of these viruses."

Lineages of human H1 and H3 viruses that were introduced earlier, however, pose the greatest risk to humans, Dr Lewis added. This is down to the low or negligible levels of cross-immunity predicted in people born since the 1970s.

Control strategies for swine flu vary by region. In the US, vaccination is used extensively to control flu in pigs, while some countries do not use vaccines at all and others produce herd-specific vaccines for individual producers. Co-author Colin Russell said the significant antigenic diversity seen in the data suggests it is "highly unlikely" that one vaccine strain per subtype would be effective globally, or even in a given region.

Researchers say their findings highlight the need for more focused surveillance in areas with high pig population density, such as China, as well as situations where pigs and humans are in close contact.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.